LORUSSO, BRUNO
 Distribuzione geografica
Continente #
EU - Europa 1.022
NA - Nord America 836
AS - Asia 378
AF - Africa 19
OC - Oceania 4
SA - Sud America 3
Totale 2.262
Nazione #
US - Stati Uniti d'America 828
IT - Italia 414
IE - Irlanda 189
CN - Cina 186
SG - Singapore 138
SE - Svezia 126
DE - Germania 69
AT - Austria 43
FI - Finlandia 36
GB - Regno Unito 29
FR - Francia 26
IN - India 21
CZ - Repubblica Ceca 20
TR - Turchia 19
BE - Belgio 18
CI - Costa d'Avorio 18
NL - Olanda 15
CA - Canada 8
UA - Ucraina 7
RU - Federazione Russa 6
LU - Lussemburgo 5
RO - Romania 5
AU - Australia 4
IR - Iran 4
ES - Italia 3
JP - Giappone 3
LT - Lituania 3
BR - Brasile 2
GR - Grecia 2
HK - Hong Kong 2
IL - Israele 2
MD - Moldavia 2
AZ - Azerbaigian 1
CH - Svizzera 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MT - Malta 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
RS - Serbia 1
Totale 2.262
Città #
Dublin 189
Chandler 159
Parma 148
Singapore 110
Santa Clara 91
Ashburn 69
Boardman 69
Ann Arbor 55
Shanghai 46
Vienna 42
Bologna 35
New York 34
Dearborn 30
Munich 25
Milan 24
Helsinki 23
Nanjing 22
Bremen 20
Beijing 19
Abidjan 18
Brussels 17
Princeton 16
Verona 15
Amsterdam 14
Izmir 14
Nanchang 12
Frankfurt am Main 11
Rio Saliceto 11
West Jordan 10
Brno 9
Carpi 9
Reggio Emilia 9
Trento 9
Chicago 8
Fremont 8
Hebei 8
Marseille 8
Olomouc 8
Rome 8
Wilmington 8
Guangzhou 7
London 7
Modena 7
Pune 6
Bolzano 5
Dallas 5
Hefei 5
Jinan 5
Kunming 5
Los Angeles 5
Seattle 5
Sector 6 5
Shenyang 5
Toronto 5
Zhengzhou 5
Assago 4
Des Moines 4
Jiaxing 4
Norwalk 4
San Mateo 4
Brescia 3
Edinburgh 3
Florence 3
Houston 3
Kolkata 3
Kyiv 3
Lonato 3
Melbourne 3
Neviano degli Arduini 3
Ottawa 3
Redwood City 3
Woodbridge 3
Athens 2
Central 2
Changsha 2
Chisinau 2
Cosenza 2
Fuzhou 2
Genova 2
Grafing 2
Hangzhou 2
Hyderabad 2
Kocaeli 2
Leytonstone 2
Marino 2
Monmouth Junction 2
Pescara 2
Phoenix 2
Piacenza 2
Sassuolo 2
Scafati 2
Sissa 2
Tehran 2
Treviso 2
Trieste 2
Vicenza 2
Viggiù 2
Yomra 2
Zevio 2
Alessandria 1
Totale 1.633
Nome #
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 125
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 120
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 98
Isolation and characterization of human lung lymphatic endothelial cells 97
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 93
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 90
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 89
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 89
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 88
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 86
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 81
Assessment of Cardiac Patches Suitability for Tissue Engineering 80
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 77
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 75
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 74
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 70
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 68
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 67
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 66
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 64
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 63
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 57
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 55
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 55
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 51
227P Sexual dimorphism in immune profile of early and advanced NSCLC 50
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 48
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 43
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 35
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 29
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 29
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 26
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 26
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 23
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 19
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 13
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 12
Totale 2.331
Categoria #
all - tutte 10.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.028


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 15 8 12 16 10 6
2020/2021119 7 10 2 7 20 12 1 4 14 7 29 6
2021/202291 8 5 2 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/2025528 63 64 92 112 113 82 2 0 0 0 0 0
Totale 2.331